8-K current report · filed Feb 25, 2026

Revolution Medicines Inc (RVMD) 8-K Current Report: February 25, 2026

Item 2.02RVMD overview

Short answer

Revolution Medicines Inc (RVMD) filed an 8-K current report with the SEC on February 25, 2026 reporting Item 2.02 (Results of Operations and Financial Condition). Full-year 2025 financial results announced Feb 25, 2026: details in Exhibit 99.1 press release.

Revolution Medicines Inc 8-K event analysis

AI summary of each reported item and its exhibits

Item 2.02 · Results of Operations and Financial Condition

  • Full-year 2025 financial results announced Feb 25, 2026: details in Exhibit 99.1 press release
  • Filing furnished (not filed), limiting legal liability under Exchange Act Section 18

Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean

Get the next RVMD 8-K as it lands

Follow RVMD for push alerts, or ask the research agent what this filing means.